| Source: |
| Type: |
| NEDD9 (Neural Precursor Cell Expressed Developmentally Downregulated 9) is a protein that has been implicated in various cellular processes, including cell adhesion, migration, and signaling. It is part of the CAS (Crk-associated substrate) family of proteins and is known to interact with several signaling pathways, particularly those involving integrins and growth factor receptors. NEDD9 is often found to be overexpressed in various types of cancers, including breast, lung, and colorectal cancers. This overexpression is associated with more aggressive tumor behavior and poorer prognosis. NEDD9 interacts with several signaling pathways, including those mediated by epidermal growth factor receptor (EGFR) and other receptor tyrosine kinases. These interactions can enhance signaling pathways that promote cell survival, proliferation, and migration. |
| 174- | Api, | Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells |
| - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | DLD1 |
| 476- | CUR, | The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer |
| - | in-vitro, | PC, | PATU-8988 | - | in-vitro, | PC, | PANC1 |
| 480- | CUR, | Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells |
| - | in-vitro, | GBM, | SNB19 |
| 1618- | EA, | A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action |
| - | Review, | BC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:527 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid